www.fdanews.com/articles/115438-us-fda-memo-backs-sanofi-heart-drug-multaq
US FDA Memo Backs Sanofi Heart Drug Multaq
March 16, 2009
An experimental drug from Sanofi-Aventis should be approved for delaying symptoms of atrial fibrillation and reducing hospitalization, a U.S. drug reviewer said in a memo.
CNN Money
CNN Money